vs

Side-by-side financial comparison of Albemarle Corporation (ALB) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Albemarle Corporation is the larger business by last-quarter revenue ($1.4B vs $1.0B, roughly 1.4× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -29.0%, a 34.5% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 15.9%). Albemarle Corporation produced more free cash flow last quarter ($233.1M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 2.4%).

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...

ALB vs ECG — Head-to-Head

Bigger by revenue
ALB
ALB
1.4× larger
ALB
$1.4B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+17.2% gap
ECG
33.2%
15.9%
ALB
Higher net margin
ECG
ECG
34.5% more per $
ECG
5.5%
-29.0%
ALB
More free cash flow
ALB
ALB
$209.6M more FCF
ALB
$233.1M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
2.4%
ALB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALB
ALB
ECG
ECG
Revenue
$1.4B
$1.0B
Net Profit
$-414.2M
$55.3M
Gross Margin
13.9%
11.6%
Operating Margin
-15.2%
6.8%
Net Margin
-29.0%
5.5%
Revenue YoY
15.9%
33.2%
Net Profit YoY
-650.1%
60.4%
EPS (diluted)
$-3.88
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALB
ALB
ECG
ECG
Q4 25
$1.4B
$1.0B
Q3 25
$1.3B
$986.8M
Q2 25
$1.3B
$921.5M
Q1 25
$1.1B
$826.6M
Q4 24
$1.2B
$759.6M
Q3 24
$1.4B
$761.0M
Q2 24
$1.4B
$703.4M
Q1 24
$1.4B
$625.7M
Net Profit
ALB
ALB
ECG
ECG
Q4 25
$-414.2M
$55.3M
Q3 25
$-160.7M
$57.0M
Q2 25
$22.9M
$52.8M
Q1 25
$41.3M
$36.7M
Q4 24
$75.3M
$34.5M
Q3 24
$-1.1B
$41.8M
Q2 24
$-188.2M
$39.0M
Q1 24
$2.4M
$28.2M
Gross Margin
ALB
ALB
ECG
ECG
Q4 25
13.9%
11.6%
Q3 25
9.0%
12.6%
Q2 25
14.8%
13.0%
Q1 25
14.5%
11.2%
Q4 24
11.2%
11.4%
Q3 24
-7.7%
11.8%
Q2 24
-0.7%
12.6%
Q1 24
2.9%
11.9%
Operating Margin
ALB
ALB
ECG
ECG
Q4 25
-15.2%
6.8%
Q3 25
-16.6%
7.3%
Q2 25
3.6%
7.9%
Q1 25
1.8%
6.2%
Q4 24
0.4%
6.1%
Q3 24
-81.9%
7.1%
Q2 24
-34.4%
7.3%
Q1 24
-13.2%
6.2%
Net Margin
ALB
ALB
ECG
ECG
Q4 25
-29.0%
5.5%
Q3 25
-12.3%
5.8%
Q2 25
1.7%
5.7%
Q1 25
3.8%
4.4%
Q4 24
6.1%
4.5%
Q3 24
-78.9%
5.5%
Q2 24
-13.2%
5.5%
Q1 24
0.2%
4.5%
EPS (diluted)
ALB
ALB
ECG
ECG
Q4 25
$-3.88
$1.09
Q3 25
$-1.72
$1.11
Q2 25
$-0.16
$1.03
Q1 25
$0.00
$0.72
Q4 24
$0.29
$0.68
Q3 24
$-9.45
$0.82
Q2 24
$-1.96
$0.76
Q1 24
$-0.08
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALB
ALB
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$3.2B
$281.5M
Stockholders' EquityBook value
$9.5B
$629.8M
Total Assets
$16.4B
$1.7B
Debt / EquityLower = less leverage
0.33×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALB
ALB
ECG
ECG
Q4 25
Q3 25
$1.9B
Q2 25
$1.8B
Q1 25
$1.5B
Q4 24
$1.2B
Q3 24
$1.7B
$553.0K
Q2 24
$1.8B
Q1 24
$2.1B
Total Debt
ALB
ALB
ECG
ECG
Q4 25
$3.2B
$281.5M
Q3 25
$3.6B
$285.1M
Q2 25
$3.6B
$288.6M
Q1 25
$3.5B
$292.1M
Q4 24
$3.5B
$295.6M
Q3 24
$3.6B
Q2 24
$3.5B
Q1 24
$3.5B
Stockholders' Equity
ALB
ALB
ECG
ECG
Q4 25
$9.5B
$629.8M
Q3 25
$10.0B
$573.0M
Q2 25
$10.2B
$514.4M
Q1 25
$10.0B
$460.2M
Q4 24
$10.0B
$422.6M
Q3 24
$10.2B
$453.3M
Q2 24
$11.2B
$490.0M
Q1 24
$11.5B
$464.3M
Total Assets
ALB
ALB
ECG
ECG
Q4 25
$16.4B
$1.7B
Q3 25
$17.1B
$1.6B
Q2 25
$17.3B
$1.5B
Q1 25
$17.0B
$1.4B
Q4 24
$16.6B
$1.3B
Q3 24
$17.5B
$1.3B
Q2 24
$18.4B
Q1 24
$19.0B
Debt / Equity
ALB
ALB
ECG
ECG
Q4 25
0.33×
0.45×
Q3 25
0.36×
0.50×
Q2 25
0.35×
0.56×
Q1 25
0.35×
0.63×
Q4 24
0.35×
0.70×
Q3 24
0.35×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALB
ALB
ECG
ECG
Operating Cash FlowLast quarter
$388.5M
$48.2M
Free Cash FlowOCF − Capex
$233.1M
$23.5M
FCF MarginFCF / Revenue
16.3%
2.3%
Capex IntensityCapex / Revenue
10.9%
2.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$692.5M
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALB
ALB
ECG
ECG
Q4 25
$388.5M
$48.2M
Q3 25
$355.6M
$76.2M
Q2 25
$-7.2M
$25.3M
Q1 25
$545.4M
$7.1M
Q4 24
$674.0K
Q3 24
$240.5M
$78.9M
Q2 24
$362.9M
Q1 24
$98.0M
$21.9M
Free Cash Flow
ALB
ALB
ECG
ECG
Q4 25
$233.1M
$23.5M
Q3 25
$223.4M
$65.7M
Q2 25
$-126.8M
$12.3M
Q1 25
$362.8M
$-11.4M
Q4 24
$-355.1M
Q3 24
$-62.6M
$60.9M
Q2 24
$-84.7M
Q1 24
$-481.4M
$12.6M
FCF Margin
ALB
ALB
ECG
ECG
Q4 25
16.3%
2.3%
Q3 25
17.1%
6.7%
Q2 25
-9.5%
1.3%
Q1 25
33.7%
-1.4%
Q4 24
-28.8%
Q3 24
-4.6%
8.0%
Q2 24
-5.9%
Q1 24
-35.4%
2.0%
Capex Intensity
ALB
ALB
ECG
ECG
Q4 25
10.9%
2.4%
Q3 25
10.1%
1.1%
Q2 25
9.0%
1.4%
Q1 25
17.0%
2.2%
Q4 24
28.9%
Q3 24
22.4%
2.4%
Q2 24
31.3%
Q1 24
42.6%
1.5%
Cash Conversion
ALB
ALB
ECG
ECG
Q4 25
0.87×
Q3 25
1.34×
Q2 25
-0.31×
0.48×
Q1 25
13.19×
0.19×
Q4 24
0.01×
Q3 24
1.89×
Q2 24
Q1 24
40.01×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALB
ALB

Energy Storage$759.1M53%
Specialties$348.9M24%
Ketjen$320.1M22%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons